However, the rarity of the events and the fact that none occur in known JIA risk loci indicate it is unlikely to be a driving mechanism of transcriptional aberrations in in CD4+ T-cells in JIA. The gene discussed is CD4; the disease is juvenile idiopathic arthritis.